China’s NMPA has approved 12 antigen self-test kits between March 12 and 16 amid COVID-19 outbreaks in many parts of the country. The regulator claims that there will soon be more test kits approved.
SHANGHAI, Dec 12 (Reuters) - Investors snapped up shares of Chinese drugmakers, mask producers, antigen test companies and funeral service providers on Monday, amid fears of soaring mass infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback